Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous Immunoglobulin Treatment of Guillain-Barré Syndrome

被引:0
|
作者
Patel, Shivam [1 ]
Le, Kim Minh Ngoc [2 ]
Puskoor, Sujith [3 ]
Amaning, Judith [2 ]
机构
[1] Texas A&M Univ, Sch Med, Bryan, TX USA
[2] Baylor Scott & White Med Ctr Round Rock, Dept Gastroenterol, Round Rock, TX 78665 USA
[3] Baylor Scott & White Med Ctr Round Rock, Dept Internal Med, Round Rock, TX USA
关键词
IVIG; Guillain-Barre syndrome; hepatitis B serology; liver enzyme elevation;
D O I
10.14309/crj.0000000000001207
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of which is Guillain-Barre syndrome. Despite its multiple benefits, IVIG can cause a wide variety of side effects, most of which resolve with supportive care. We present a case in which a patient with new-onset Guillain-Barre syndrome was treated with IVIG and subsequently developed an acute elevation in liver enzymes with positive hepatitis B serology.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Pharmacokinetics, efficacy and safety of human hepatitis B immunoglobulin for intravenous and intramuscular use in prophylaxis of hepatitis B after liver transplantation
    Burra, Patrizia
    Andreone, P.
    Volpes, R.
    Canova, D.
    Cursaro, C.
    Riili, A.
    Fiorentino, B.
    Bacci, M.
    Guazzini, S.
    Marzano, A.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 36 - 36
  • [42] Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barre syndrome
    Gisslén, M
    Fredman, P
    Fuchs, D
    Lekman, A
    Rosengren, L
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (11-12) : 877 - 881
  • [43] Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain-Barré syndrome associated with anti-GM1b IgG antibody
    Keiichiro Susuki
    Ken Johkura
    Nobuhiro Yuki
    Osamu Hasegawa
    Yoshiyuki Kuroiwa
    Journal of Neurology, 2001, 248 : 148 - 150
  • [44] Guillain-Barrè syndrome after treatment with anti-tumour necrosis factor α (etanercept) in a rheumatoid arthritis patient: Case report and literature review
    Doden, Mera H.
    Manasra, Mahmoud R.
    Abuirayyeh, Bara M.
    Al-Ihribat, Alaa R.
    Albandak, Maram
    SCIENCE PROGRESS, 2024, 107 (04)
  • [45] Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
    Riccardo Volpes
    Patrizia Burra
    Giacomo Germani
    Matteo Angelo Manini
    Lucio Caccamo
    Paolo Strignano
    Giorgia Rizza
    Mariarosa Tamè
    Antonio Daniele Pinna
    Fulvio Calise
    Carla Migliaccio
    Paola Carrai
    Paolo De Simone
    Maria Filippa Valentini
    Luigi Giovanni Lupo
    Gabriella Cordone
    Francesco Paolo Picciotto
    Antonio Nicolucci
    Health and Quality of Life Outcomes, 18
  • [46] Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
    Volpes, Riccardo
    Burra, Patrizia
    Germani, Giacomo
    Manini, Matteo Angelo
    Caccamo, Lucio
    Strignano, Paolo
    Rizza, Giorgia
    Tame, Mariarosa
    Pinna, Antonio Daniele
    Calise, Fulvio
    Migliaccio, Carla
    Carrai, Paola
    De Simone, Paolo
    Valentini, Maria Filippa
    Lupo, Luigi Giovanni
    Cordone, Gabriella
    Picciotto, Francesco Paolo
    Nicolucci, Antonio
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [47] Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
    Burbach, GJ
    Bienzle, U
    Neuhaus, R
    Hopf, U
    Metzger, WG
    Pratschke, J
    Neuhaus, P
    TRANSPLANTATION, 1997, 63 (03) : 478 - 480
  • [48] Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation
    Hooman, Nazanin
    Rifai, Kinan
    Hadem, Johannes
    Vaske, Bernhard
    Philipp, Gunnar
    Priess, Andrea
    Klempnauer, Juergen
    Tillmann, Hans L.
    Manns, Michael P.
    Rosenau, Jens
    LIVER TRANSPLANTATION, 2008, 14 (04) : 435 - 442
  • [49] Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients
    Ishigami, Masatoshi
    Onishi, Yasuharu
    Ito, Takashi
    Katano, Yoshiaki
    Ito, Akihiro
    Hirooka, Yoshiki
    Kiuchi, Tetsuya
    Goto, Hidemi
    HEPATOLOGY RESEARCH, 2011, 41 (12) : 1189 - 1198
  • [50] False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin
    de Beer, F.
    Schreurs, M. W. J.
    Foncke, E. M. J.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (07) : 643 - 644